There are times when a watchlist is more important than a buy list. But if you still insist on putting money in the market, look at fundame...

On September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracte...

Cipla said its US unit has entered an exclusive partnership with China’s Qilu Pharmaceutical to license QL2107, a biosimilar of Merck’s can...

Aurobindo Pharma announced its subsidiary Lannett Company LLC's facility inspection concluded. The US Food and Drug Administration conducte...

Zydus Lifesciences secured final USFDA approval for its generic ascorbic acid injection. This approval is for the treatment of scurvy in sp...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...

The New Jersey-based Aurobindo Pharma USA Inc initiated the Class 1 recall on July 11, it said. As per the US health regulator, a Class I r...

While Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid.

"The drug falls in the CNS stimulant segment and is the first product to be developed by the R&D team at Nesher," it added.

Micro Labs is voluntarily recalling 54,096 bottles of Simvastatin Tablets, a drug for lowering cholesterol, in the US market for failing to...

In many cases, these companies have been barred from selling their drugs in the US and other countries, although Indian firms account for a...

Drug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in US, according to the US Food and Dru...

The recall of the 5,400 bottles has been voluntarily initiated by the company through its US based arm Zydus Pharmaceuticals USA Inc.

Ranbaxy facilities in India are being reviewed after its US arm admitted to manufacturing certain drugs not in conformity with good practic...

Ranbaxy has assured the public that drugs manufactured locally are safe days after the Indian firm paid a fine of $500 million in the US.

Ranbaxy pleaded guilty to felony charges related to drug safety & will pay $500 mn in fines under settlement agreement with US Department o...